Abstract
ANGIOTENSIN II, a circulating peptide which regulates electrolyte balance by controlling the adrenal release of aldosterone, may also act on the central nervous system. The reported central effects include elevations of blood pressure1–6, drinking behaviour7–11, adrenocorticotrophic hormone release12,13 and antidiuretic hormone (ADH) release5,14,15. The evidence for ADH release from the supraoptico-neurohypophysial system is based on studies involving the parenteral and intraventricular administration of angiotensin II. These routes of administration make an exact localization of the releasing action impossible and therefore we have attempted to locate the site by applying angiotensin II directly to individual supraoptic neurosecretory cells. We now report that angiotensin II increases the discharge rate of these and other neurones in the supraoptic nucleus.
This is a preview of subscription content, access via your institution
Access options
References
Bickerton, R. K., and Buckley, J. P., Proc. Soc. Exp. Biol. Med., 106, 834 (1961).
Severs, W. B., Daniels, A. E., and Buckley, J. P., Intern. J. Neuropharmacol., 6, 199 (1967).
Cranston, W. T., Lavery, H., Lowe, R. D., and Rosendorff, C., J. Physiol., 198, 30P (1968).
Ueda, H., Ucheda, Y., Ueda, K., Gondaira, T., and Katayama, S., Jap. Heart. J., 10, 243 (1969).
Severs, W. B., Summy-Long, J., Taylor, J. S., and Connor, J. D., J. Pharmacol. Exp. Ther., 174, 27 (1970).
Deuben, R. R., and Buckley, J. P., J. Pharmacol. Exp. Ther., 175, 139 (1970).
Epstein, A. N., Fitzsimons, J. T., and Simons, B. J., J. Physiol., 200, 98P (1969).
Andersson, B., and Westbye, O., Nature, US, 75 (1970).
Andersson, B., and Westbye, O., Life Sci., 9, 601 (1970).
Epstein, A. N., Fitzsimons, J. T., and Rolls, B. J., J. Physiol., 210, 457 (1970).
Andersson, B., and Eriksson, L., Acta Physiol. Scand., 81, 18 (1971).
Redgate, E. S., Endocrinology, 82, 704 (1968).
DeWied, D., Witter, A., Versteeg, D. H. G., and Mulder, A. A., Endocrinology, 85, 561 (1969).
Bonjour, J. P., and Malvin, R. L., Amer. J. Physiol, 218, 1555 (1970).
Mouw, D., Bonjour, J. P., Malvin, R. L., and Vander, A. J., Amer. J. Physiol., 220, 239 (1971).
Salmoiraghi, G. C., and Weight, F. F., Anesthesiology 28, 54 (1967).
Barker, J. L., Crayton, J. W., and Nicoll, R. A., Science, 171, 206 (1971).
Barker, J. L., Crayton, J. W., and Nicoll, R. A., Science, 171, 208 (1971).
Fitzsimons, J. T., and Simons, B., J. Physiol, 203, 45 (1969).
DeMoura, R. S., DeSonza Martins, S. A., and Sollero, L., Pharmacology, 3, 15 (1970).
Hughes, J., and Roth, R. H., Brit. J. Pharmacol., 41, 239 (1971).
Krnjevic, K., and Phillis, J. W., Brit. J. Pharmacol., 20, 471 (1963).
Legge, K. F., Randic, M., and Straughan, D. W., Brit. J. Pharmacol., 26, 87 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
NICOLL, R., BARKER, J. Excitation of Supraoptic Neurosecretory Cells by Angiotensin II. Nature New Biology 233, 172–174 (1971). https://doi.org/10.1038/newbio233172a0
Received:
Issue date:
DOI: https://doi.org/10.1038/newbio233172a0
This article is cited by
-
Angiotensin II as a factor inhibiting the fear response
Neuroscience and Behavioral Physiology (1987)
-
Effects of naloxone on renal responses to noxious stimuli in the cynomolgus monkey
Primates (1986)
-
Angiotensin excites hippocampal pyramidal cells by two mechanisms
Cellular and Molecular Neurobiology (1982)